Brainstorm Cell Therapeutics | BCLI - Loan Capital

Stock Price
0.85
Daily Change
-0.02 -1.73%
Monthly
-5.56%
Yearly
6.92%
Q2 Forecast
0.90

Brainstorm Cell Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Cipla INR 2.98B 454.6M Sep/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Cytokinetics USD 1.12B 957.23M Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
Grifols EUR 9.95B 722.93M Dec/2025
Halozyme Therapeutics USD 2.14B 1.34B Dec/2025
Mesoblast USD 66.02M 1.72M Dec/2025